Hey Buildit, I couldn't agree more with your post.

New Post Public Reply Private Reply Replies (1) Message Board
Zolis_onkel Buildit #26730
377
Hey Buildit,

I couldn't agree more with your post. Special thanks to you also to search through the CC transcript to find the appropriate statements made in the CC.
It is one thing to feel mislead, but it something entirely else to find the exact statements in the transcript, which I agree cannot be understood any different than you suggest. I also clearly understood during the CC that WE, THE SHAREHOLDERS, should receive a final information of the mouse testing results within the next 7-10 days. And even that is actually already delayed compared to the statements Joe made during that YouTube interview to the "Great Wize Oz" guys, where he stated that these test results should already be available end of January or the first week of Feb, which I assumed to be the reason why they scheduled the CC for the Feb. 5th date. I was willing to accept that due to whatever reasons this got delayed by yet another week or so (7-10 days), but now hearing that this will take - most likely - another SEVERAL weeks, does really upset me. Esepcially when I read from your post, that this was not just my interpretation of what I heard during the CC, but you provide clear evidence from the transcript that cannot be read in any different way than Joe clearly stating that the laboratory results will be made public to us shareholders no later than 2 weeks (10 business days) after the CC. I see this exactly the same way as you are, and understand why you are upset.

In general, I can only repeat myself from similar discussions we've had in the past, and say

ACCOUNTABILITY, ACCOUNTABILITY and once again ACCOUNTABILIY is what Joe and his management team really need.

No matter if this a promise made to a friend, co-worker or my boss, if I promise to deliver something latest within 10 business days, and then something unforseeable happens, which makes it impossible to keep my promise. The least I HAVE TO DO is to contact that person, give the reasons why it is delayed and make a new prediction as to when I will be able to deliver whatever I promised. In any case, I think that everyone involved at least deserves to be informed and an apology for the delay.

But all we typically receive from Mr. Moscato is insults. I am not really sure what he personally thinks right now, about what we discuss here, but in the past we were called idiots or stupid, because we assumed that "in the coming days" meant to receive an update or PR within at max. a week after the related announcment.

I think what we've got here is a disconnect between what we do get told about the current situation within the company and what we, as the shareholders, really want or even need to hear. A good example is the lengthy biochemstry lecture we received from Mr. Purcell during the CC, but when it finally was supposed to get interesting related to the results, we received nothing but a " you need to be a little bit more patient" message. I guess most of us shareholders would first of like to hear an executive summary, and leave details for a potential answer to a question of an interested person. And what we, as shareholders, need even more is reliability of promises made. And with that we actually need to speak "the same language" as far as "hearing about results" is concerned as well as what regularly used phrases such as "in the coming days" or "within the next 7-10 days" really mean. These should NEVER be a subject to interpretation, but 100% certainty of what is meant by them, and then kept as promised.

So, Mr. Moscato, assuming that you follow this message board as you did in the past. I can only ask you for one important thing, and that is:

PUBLISH A PR EARLY NEXT WEEK; AND UPDATE US ALL ON THE CURRENT SITUATION INCLUDING RELIABLE TIMELINES TOWARDS THE NEXT IMPORTANT MILESTONES, SUCH AS FDA APPLICATION TO START CLINICAL TRIALS, THE NEXT STEPS IN THE CHINA AFFAIRS AND IPO FOR NGIO.

Looking forward hearing from you in this regard.

Regards,

Zolis_onkel
1

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 59

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 78

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 80

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 58

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 60

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 72

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 67

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading

Top 5 Most Recently Viewed Articles

EYLEA HD® Injection Receives FDA Approval for RVO Treatment

Updated Category News Views 146

EYLEA HD® Injection: A Milestone in Treating Macular Edema First and only FDA-approved treatment for retinal vein occlusion (RVO) indicated for up to every 8-week dosing after an initial monthly regimen. Flexible Dosing Options for Enhanced Patient Care The recent FDA approval for EYLEA HD® (aflibercept) Injection 8 mg is a major advancement. This treatment is...

Continue Reading
Trifork Group's Recent Share Buyback Program Overview

Updated Category News Views 188

Overview of Trifork Group's Share Buyback Program The Trifork Group has recently initiated a significant share buyback program to enhance shareholder value and optimize its capital structure. This strategic decision underscores the company's commitment to returning value to its investors while maintaining a strong financial position. Details of the Share Buyback...

Continue Reading
Raymond James Celebrates Unmatched Milestone of 150 Quarters

Updated Category News Views 150

Remarkable Achievement in Consistent Profitability Raymond James has proudly reached a significant milestone of 150 consecutive quarters of profitability, showcasing nearly four decades of unwavering strength. This accomplishment highlights the firm’s resilience and dedication to its values. Guided by seasoned leaders including Chair Emeritus Tom James, Chair Paul...

Continue Reading
Innovative Cozy Sleeper Berth Light Designed for Truckers

Updated Category News Views 178

Introducing the Cozy Sleeper Berth Light The Cozy Sleeper Berth Light, developed by an innovative inventor, aims to transform the way truck drivers experience rest periods. This convenient lighting solution addresses the common issue of harsh lighting or total darkness that many drivers face while resting in their sleeper berths. The Invention's Unique Features The Cozy...

Continue Reading
ON Semiconductor Drives Innovation Amid Chip Market Changes

Updated Category News Views 141

ON Semiconductor's Recent Performance ON Semiconductor Corp (NASDAQ: ON) has recently experienced a boost following its latest earnings report. The company shared its fiscal third-quarter results, leading to an increase in stock value, reflecting investor confidence amidst ongoing fluctuations in the semiconductor sector. Quarterly Financial Highlights The latest figures...

Continue Reading